GHP Global Excellence Awards 2022 GHP / Q1 2022 37 Improving Clinical Trials Worldwide opportunities and challenges for each client. Each of these descriptors relates to aspects of Exom Group’s vision. Firstly, transformation alludes to its ability to mould and reshape clinical trial logistics, remodelling the future of clinical trials and research in order to create the future of this industry, one that will no doubt continue to be a linchpin of the modern world long into the future. Its advanced digital technological offerings, newly re-engineered operational processes, and more assure the achievement of the highest quality of standards, preventing any risk that could potentially harm study results and cause extraneous variables to confound the data. With its operational prowess, its data-driven management, and risk-based monitoring – using DDM and RBM specifically – it improves the approaches implemented by it, reducing the overall costs, whilst increasing quality and performance. In addition, its research professionals seek to provide the utmost therapeutic experience for its clients when it comes to the observation of clinical trials. Sharing an in-depth passion for expertise, great performance, digital clinical trial element creation, and new working processes that make clinical research easier for all involved, it boasts a solid foundation of experience and years in clinical trial conduct that has helped with the research into everything from infectious disease to central nervous system disorders and immunology. In the coming year, it is excited to help many more clinical trial experts with their studies, looking forward to emboldening the studies and processes of its industry even further in the coming year. Company: Exom Group Contact: Luigi Visani Website: exomgroup.com
RkJQdWJsaXNoZXIy MTQxNTg3MQ==